Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Merck KGaA
Merck KGaA
Merck KGaA to Consolidate Its Silicon Valley Innovation Sites
BioSpace
Thu, 03/4/21 - 11:30 pm
Merck KGaA
Silcon Valley
innovation
Merck KGaA pens $855M upfront, biobucks pact with Debiopharm for next-gen cancer asset
Fierce Biotech
Mon, 03/1/21 - 10:32 am
Merck KGaA
Debiopharm
biobucks
Bavencio
Debio1143
xevinapant
Merck KGaA offloads clinical-phase cancer drugs to Day One
Fierce Biotech
Tue, 02/23/21 - 10:45 am
Merck KGaA
Day One Biopharmaceuticals
pimasertib
solid tumors
Pharma’s pipeline continues to provide drama as investors look beyond COVID in Q4
Pharmaforum
Fri, 02/19/21 - 10:33 am
pharma industry
R&D
pandemic
earnings
COVID-19
Biogen
GW Pharma
Jazz Pharmaceuticals
GSK
Merck KGaA
BioNTech Gets Help From Merck KGaA in Move to Speed Covid Shots
Bloomberg
Sat, 02/6/21 - 10:43 pm
Merck KGaA
BioNTech
COVID-19
vaccines
FDA Approves Merck KGaA's Tepmetko for Aggressive Lung Cancer
BioSpace
Wed, 02/3/21 - 11:04 pm
Merck KGaA
Tepmetko
FDA
metastatic non-small cell lung cancer
GSK, German Merck's $4.2B bintrafusp alfa drug a bust, fails to beat king Keytruda in lung cancer
Fierce Biotech
Wed, 01/20/21 - 10:48 am
GSK
Merck KGaA
bintrafusp alfa
clinical trial
Merck
Keytruda
Ex-Gilead execs bag $80M to trial drug licensed from Merck KGaA
Fierce Biotech
Tue, 01/19/21 - 10:38 am
Vera Therapeutics
Merck KGaA
clinical trials
kidney disease
atacicept
Gilead Sciences
Better Together – Merck KGaA Announces Collaboration with Artios
BioSpace
Thu, 12/3/20 - 11:01 am
Merck KGaA
Artios Pharma
drug development
cancer
oncology
Merck KGaA Diversifies with First Female CEO
BioSpace
Tue, 09/29/20 - 11:27 pm
Merck KGaA
Female Executives
Pharma CEOs
Belén Garijo
ESMO: Pfizer, Merck KGaA's Bavencio comes up short against placebo in risky head and neck cancer trial
Fierce Pharma
Sat, 09/19/20 - 09:20 pm
ESMO
Pfizer
Merck KGaA
Bavencio
head and neck cancer
clinical trials
Merck KGaA : to Invest EUR59 Million to Expand Pharmaceutical Manufacturing at US Facility
Market Screener
Wed, 09/9/20 - 11:02 am
drug manufacturing
Merck KGaA
Big pharma spinouts grow up
EP Vantage
Tue, 09/8/20 - 10:53 am
Big Pharma
spinoffs
Merck KGaA
Pfizer
GSK
Novartis
Roche
Sanofi
JNJ
AstraZeneca
FDA starts quick review of Merck KGaA’s MET-targeting lung cancer drug
Pharmaforum
Wed, 08/26/20 - 11:03 am
Merck KGaA
MET inhibitors
tepotinib
lung cancer
Merck KGaA picks up another anticancer bispecific from F-star
Fierce Biotech
Fri, 07/17/20 - 11:07 am
Merck KGaA
F-star Therapeutics
immuno-oncology
bispecific antibodies
Merck KGaA's manufacturing group could see billions from COVID-19 work: analyst
Fierce Pharma
Tue, 07/14/20 - 11:27 pm
COVID-19
vaccines
drug manufacturing
Merck KGaA
Merck KGaA’s ATR cancer drug cleared for further trials after phase 1 trial success
Pharmaforum
Tue, 06/23/20 - 10:46 am
Merck KGaA
cancer
clinical trials
DNA repair
Marketing In another round of Merck vs. Merck, Germany-based Merck KGaA notches a win in the U.K.
Fierce Pharma
Mon, 06/1/20 - 11:39 pm
Merck
Merck KGaA
trademark
ASCO: Pfizer, Merck KGaA's Bavencio posts win in rare gynecological cancer
Fierce Pharma
Thu, 05/28/20 - 11:08 pm
Pfizer
Merck KGaA
Bavencio
ASCO 2020
bladder cancer
gestational trophoblastic tumors
clinical trials
Newron's Merck KGaA-in licensed compound fails Rett Syndrome study, shares wilt
Endpoints
Mon, 05/4/20 - 10:32 am
Newron Pharma
Merck KGaA
Rett Syndrome
sarizotan
clinical trials
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »